Home Page Xermelo

Step 1: Patient Information

First Name*

Last Name*

Email Address

Mailing Address*

Mailing Address 2 (optional)

City*

State*

ZIP Code*

Phone Number*

*Required field

Step 2: Eligibility Question

What type of prescription drug insurance do you have?*

Commercial prescription drug insurance through an employer-sponsored or private health plan or the Federal Employee Health Benefit Plan.

Prescription insurance coverage through a state or federal healthcare program, including but not limited to Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA) or Department of Defense (DOD) programs.

I am not covered by prescription drug insurance.

TerSera Therapeutics LLC will use the personal information in this form, including contact, prescription, insurance, and medical condition to enroll you in the XERMELO Savings Program and send you related communications. You can terminate your enrollment at any time. For more information, visit https://tersera.com/privacy-policy.

Click here to view the XERMELO Co-pay Program Terms and Conditions.

Important Safety Information and Indication

Important Safety Information

Do not take XERMELO if you have a history of hypersensitivity to telotristat or any of the ingredients in XERMELO.
XERMELO may cause constipation which can be serious. You should stop taking XERMELO if severe constipation or severe, persistent, or worsening abdominal pain develops. Talk to your doctor if you have these symptoms.
The most common side effects of XERMELO include nausea, headache, increase in liver enzymes, depression, flatulence, decreased appetite, swelling of your hands and feet, fever, abdominal pain, and constipation.
Talk to your doctor about all medications you are taking as some may interact with XERMELO.
XERMELO is not recommended if you have moderate or severe liver impairment.

Indication

XERMELO is a prescription pill, used along with somatostatin analog (SSA) therapy, for carcinoid syndrome diarrhea in adults who are not adequately controlled by SSA therapy.

Please see Full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA.

To report suspected adverse reactions, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also contact TerSera Therapeutics at 1-844-334-4035 or medicalinformation@tersera.com.

Important Safety Information and Indication

Important Safety Information

Do not take XERMELO if you have a history of hypersensitivity to telotristat or any of the ingredients in XERMELO.
XERMELO may cause constipation which can be serious. You should stop taking XERMELO if severe constipation or severe, persistent, or worsening abdominal pain develops. Talk to your doctor if you have these symptoms.
The most common side effects of XERMELO include nausea, headache, increase in liver enzymes, depression, flatulence, decreased appetite, swelling of your hands and feet, fever, abdominal pain, and constipation.

Get started with XERMELO

Step 1: Patient Information

Step 2: Eligibility Question

Important Safety Information and Indication

Important Safety Information

Indication

Important Safety Information and Indication

Important Safety Information